Bionano Genomics, Inc. Warrant
BNGOW
BNGOW was delisted on the 17th of August, 2023.
2 hedge funds and large institutions have $132 invested in Bionano Genomics, Inc. Warrant in 2023 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
92% less capital invested
Capital invested by funds: $1.7K → $132 (-$1.57K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$2.94K |
BNGOW Hedge Fund Activity: Q1 2023 in Review
2 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics, Inc. Warrant (BNGOW) for Q1 2023, worth a combined $132 — down 92% from $1.7K a quarter earlier.
Fund positioning in BNGOW was balanced in Q1 2023: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was UBS Group, cutting an estimated $2.94K.
- 2 institutional investors held Bionano Genomics, Inc. Warrant (BNGOW) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $132 of Bionano Genomics, Inc. Warrant stock for Q1 2023, down 92% quarter-over-quarter.
- 0 funds opened new Bionano Genomics, Inc. Warrant positions in Q1 2023 and 0 closed out.
- The largest Bionano Genomics, Inc. Warrant seller in Q1 2023 was UBS Group, an estimated $2.94K sold.
Based on aggregated 13F filings for Q1 2023.